Mimedx (MDXG) Other Accumulated Expenses (2011 - 2026)

Mimedx has disclosed Other Accumulated Expenses across 16 years of filings, most recently posting $6.1 million for Q1 2026.

• Other Accumulated Expenses for Q1 2026 came in at $6.1 million, up 36.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.1 million (up 36.51% YoY), and the FY2025 annual result was $5.8 million, up 28.47% from the prior year.
• Other Accumulated Expenses came in at $6.1 million for Q1 2026 at Mimedx, up from $5.8 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $6.1 million in Q1 2026 to a low of $1.6 million in Q1 2022.
• The 5-year median for Other Accumulated Expenses is $2.6 million (2024), against an average of $3.1 million.
• Across the five-year window, Other Accumulated Expenses slipped 6.04% in 2022 and jumped 126.92% in 2024, its largest moves.
• Mimedx's Other Accumulated Expenses stood at $1.8 million in 2022, then jumped by 57.8% to $2.9 million in 2023, then surged by 55.74% to $4.5 million in 2024, then grew by 28.47% to $5.8 million in 2025, then grew by 4.56% to $6.1 million in 2026.
• The last three Other Accumulated Expenses figures came in at $6.1 million (Q1 2026), $5.8 million (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.